164 related articles for article (PubMed ID: 36907069)
1. Extracellular volume fraction determined by dual-layer spectral detector CT: Possible role in predicting the efficacy of preoperative neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma.
Fujita N; Ushijima Y; Itoyama M; Okamoto D; Ishimatsu K; Wada N; Takao S; Murayama R; Fujimori N; Nakata K; Nakamura M; Yamamoto T; Oda Y; Ishigami K
Eur J Radiol; 2023 May; 162():110756. PubMed ID: 36907069
[TBL] [Abstract][Full Text] [Related]
2. Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nakajo M; Maemura K; Arima S; Yoshiura T
Eur Radiol; 2020 Mar; 30(3):1679-1689. PubMed ID: 31728691
[TBL] [Abstract][Full Text] [Related]
3. Extracellular volume fraction with MRI: As an alternative predictive biomarker to dynamic contrast-enhanced MRI for chemotherapy response of pancreatic ductal adenocarcinoma.
Fukukura Y; Kumagae Y; Fujisaki Y; Nakamura S; Dominik Nickel M; Imai H; Yoshiura T
Eur J Radiol; 2021 Dec; 145():110036. PubMed ID: 34814039
[TBL] [Abstract][Full Text] [Related]
4. Assessing Chemotherapeutic Response in Pancreatic Ductal Adenocarcinoma: Histogram Analysis of Iodine Concentration and CT Number in Single-Source Dual-Energy CT.
Noda Y; Goshima S; Miyoshi T; Kawada H; Kawai N; Tanahashi Y; Matsuo M
AJR Am J Roentgenol; 2018 Dec; 211(6):1221-1226. PubMed ID: 30332288
[TBL] [Abstract][Full Text] [Related]
5. Prediction of pancreatic fibrosis by dual-energy CT-derived extracellular volume fraction: Comparison with MRI.
Sun S; Huang B; Li Q; Wang C; Zhang W; Xu L; Xu Q; Zhang Y
Eur J Radiol; 2024 Jan; 170():111204. PubMed ID: 37988962
[TBL] [Abstract][Full Text] [Related]
6. Synthetic Extracellular Volume Fraction Derived Using Virtual Unenhanced Attenuation of Blood on Contrast-Enhanced Cardiac Dual-Energy CT in Nonischemic Cardiomyopathy.
Kim NY; Im DJ; Youn JC; Hong YJ; Choi BW; Kang SM; Lee HJ
AJR Am J Roentgenol; 2022 Mar; 218(3):454-461. PubMed ID: 34643105
[No Abstract] [Full Text] [Related]
7. Estimation of Extracellular Volume Fraction With Routine Multiphasic Pancreatic Computed Tomography to Predict the Survival of Patients With Stage IV Pancreatic Ductal Adenocarcinoma.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nakajo M; Maemura K; Arima S; Yoshiura T
Pancreas; 2019; 48(10):1360-1366. PubMed ID: 31688602
[TBL] [Abstract][Full Text] [Related]
8. Utility of Dark-Blood Dual-Energy CT Images for Predicting Vascular Involvement and R0 Resection in Patients With Pancreatic Cancer.
Si K; Wu H; Yang M; Guo Y; Zhang X; Ding C; Xue J; Han P; Li X
AJR Am J Roentgenol; 2023 Jun; 220(6):838-848. PubMed ID: 36541594
[No Abstract] [Full Text] [Related]
9. Dual-layer spectral detector CT: A noninvasive preoperative tool for predicting histopathological differentiation in pancreatic ductal adenocarcinoma.
Liu W; Xie T; Chen L; Tang W; Zhang Z; Wang Y; Deng W; Xie X; Zhou Z
Eur J Radiol; 2024 Apr; 173():111327. PubMed ID: 38330535
[TBL] [Abstract][Full Text] [Related]
10. Dual-energy computed tomography in a multiparametric regression model for diagnosing lymph node metastases in pancreatic ductal adenocarcinoma.
Li S; Jiang D; Jiang L; Yan S; Liu L; Ruan G; Zhou X; Zhuo S
Cancer Imaging; 2024 Mar; 24(1):38. PubMed ID: 38504330
[TBL] [Abstract][Full Text] [Related]
11. Myocardial extracellular volume fraction analysis in doxorubicin-induced beagle models: comparison of dual-energy CT with equilibrium contrast-enhanced single-energy CT.
Zhou Z; Gao Y; Wang H; Wang W; Zhang H; Wang S; Sun Z; Xu L
Cardiovasc Diagn Ther; 2021 Feb; 11(1):102-110. PubMed ID: 33708482
[TBL] [Abstract][Full Text] [Related]
12. Estimation of Fractional Extracellular Space at CT for Predicting Chemotherapy Response and Survival in Pancreatic Ductal Adenocarcinoma.
Wang ZJ; Zhang TT; An C; Ko AH; Tempero M; Collisson E; Yeh BM
AJR Am J Roentgenol; 2020 Sep; 215(3):610-616. PubMed ID: 32755156
[No Abstract] [Full Text] [Related]
13. Development and validation of a model for predicting the expression of Ki-67 in pancreatic ductal adenocarcinoma with radiological features and dual-energy computed tomography quantitative parameters.
Wen Y; Song Z; Li Q; Zhang D; Li X; Yu J; Li Z; Ren X; Zhang J; Liu Q; Huang J; Zeng D; Tang Z
Insights Imaging; 2024 Feb; 15(1):41. PubMed ID: 38353857
[TBL] [Abstract][Full Text] [Related]
14. Quantitative and Qualitative Comparison of Single-Source Dual-Energy Computed Tomography and 120-kVp Computed Tomography for the Assessment of Pancreatic Ductal Adenocarcinoma.
Bhosale P; Le O; Balachandran A; Fox P; Paulson E; Tamm E
J Comput Assist Tomogr; 2015; 39(6):907-13. PubMed ID: 26295192
[TBL] [Abstract][Full Text] [Related]
15. Extracellular volume fraction determined by equilibrium contrast-enhanced multidetector computed tomography as a prognostic factor in unresectable pancreatic adenocarcinoma treated with chemotherapy.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Takumi K; Maemura K; Higashi M; Kamimura K; Nakajo M; Yoshiura T
Eur Radiol; 2019 Jan; 29(1):353-361. PubMed ID: 29922930
[TBL] [Abstract][Full Text] [Related]
16. Predicting Treatment Response From Extracellular Volume Fraction for Chemoradiation Therapy of Pancreatic Cancer.
Noid G; Godfrey G; Hall W; Shah J; Paulson E; Knechtges P; Erickson B; Allen Li X
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):803-808. PubMed ID: 36210026
[TBL] [Abstract][Full Text] [Related]
17. Simulated twin-phase pancreatic CT generated using single portal venous phase dual-energy CT acquisition in pancreatic ductal adenocarcinoma.
Noda Y; Tochigi T; Parakh A; Kambadakone A
Abdom Radiol (NY); 2021 Jun; 46(6):2610-2619. PubMed ID: 33454806
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Accuracy of Attenuation Difference and Iodine Concentration Thresholds at Rapid-Kilovoltage-Switching Dual-Energy CT for Detection of Enhancement in Renal Masses.
Sadoughi N; Krishna S; Macdonald DB; Chatelain R; Flood TA; McInnes MDF; Schieda N
AJR Am J Roentgenol; 2019 Sep; 213(3):619-625. PubMed ID: 31120787
[No Abstract] [Full Text] [Related]
19. Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode.
Yin Q; Zou X; Zai X; Wu Z; Wu Q; Jiang X; Chen H; Miao F
Eur J Radiol; 2015 Dec; 84(12):2470-6. PubMed ID: 26481480
[TBL] [Abstract][Full Text] [Related]
20. Dual-layer spectral CT improves image quality of multiphasic pancreas CT in patients with pancreatic ductal adenocarcinoma.
Nagayama Y; Tanoue S; Inoue T; Oda S; Nakaura T; Utsunomiya D; Yamashita Y
Eur Radiol; 2020 Jan; 30(1):394-403. PubMed ID: 31312889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
